Track Kintara Therapeutics's long-term debt ($190K) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Kintara Therapeutics (KTRA) currently reports a long-term debt of $190K as of June 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Kintara Therapeutics's long-term debt history and peer comparisons.
Kintara Therapeutics's long-term debt changed from $0 to $190K (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Kintara Therapeutics reported $190K in long-term debt as of June 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current long-term debt of $190K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Kintara Therapeutics, and consider following KTRA for alerts when major investors trade the stock.
Kintara Therapeutics is classified in the Materials sector. On long-term debt, it currently shows $190K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Materials are usually more informative than comparing KTRA with unrelated industries.